Contact

Northward Orchard Home About Services Safety & Risks Player Guidance Evidence Review Contact Evidence, uncertainty, safety Ibogaine for Rugby A careful look at contact-sport brain injury, mental health, addiction treatment claims, and the serious safety questions surrounding a high-risk psychoactive substance. Northward Orchard is an independent resource on ibogaine, rugby, and informed risk. This page does not recommend treatment or replace individual medical or legal advice. Start with the limits A question with no shortcut Interest in ibogaine for rugby arises where repeated concussion, traumatic brain injury, chronic pain, opioid addiction, anxiety, depression, and difficult retirement experiences overlap. That interest is understandable; it is not proof of a safe or effective treatment. Rugby players face physical injuries and repeated head impacts in a sport where player welfare requires attention long after a match or career ends. A 2017 British Journal of Sports Medicine study reported an average of 7–8 concussions per 1,000 player hours among professional rugby players, a figure that helps show why concussion management and rehabilitation remain central concerns. For a broad orientation to the topic, ibogaine and rugby context can help frame the questions, while the discussion of rugby-player treatment claims should be read as background rather than confirmation of outcomes. Safety first Cardiac issues, medication interactions, and adverse effects cannot be separated from the conversation. Evidence over hype Clinical studies for traumatic brain injury in athletes remain limited and incomplete. Plain language Anecdotal reports may matter to individuals, but they do not establish long-term benefits. The origin of a substance does not determine its safety in a modern treatment setting. Properties and context Understanding a complex drug Ibogaine is a naturally occurring psychoactive alkaloid derived from the root bark of the Tabernanthe iboga plant, native

A clear route, when one is published.